(Q37313483)

19 August 2017

1 reference

title

Fibromyalgia: should the treatment paradigm be monotherapy or combination pharmacotherapy? (English)

1 reference

19 August 2017

0 references

0 references

Philip J Mease

1

1 reference

PubMed ID

18973731

19 August 2017

Kristin Seymour

series ordinal

2

1 reference

PubMed ID

18973731

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Current Pain and Headache Reports

19 August 2017

1 reference

19 August 2017

12

1 reference

19 August 2017

6

1 reference

19 August 2017

399-405

1 reference

https://scigraph.springernature.com/pub.10.1007/s11916-008-0068-4

19 August 2017

0 references

cites work

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

1 reference

https://api.crossref.org/works/10.1007%2FS11916-008-0068-4

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-008-0068-4

Therapy Insight: fibromyalgia--a different type of pain needing a different type of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-008-0068-4

A randomized, double-blind, placebo-controlled clinical trial using a low-frequency magnetic field in the treatment of musculoskeletal chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11916-008-0068-4

21 January 2018

The Serotonin Syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11916-008-0068-4

Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial

21 January 2018

1 reference

12 December 2020

A meta-analysis of fibromyalgia treatment interventions.

1 reference

12 December 2020

A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia

1 reference

12 December 2020

Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises.

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

1 reference

12 December 2020

Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorder

1 reference

12 December 2020

Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures, and treatment

1 reference

12 December 2020

Evaluation and management of endocrine dysfunction in fibromyalgia

1 reference

12 December 2020

Fibromyalgia syndrome

1 reference

12 December 2020

Abnormal responses to electrocutaneous stimulation in fibromyalgia

1 reference

12 December 2020

Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Fibromyalgia syndrome

1 reference

12 December 2020

An internet survey of 2,596 people with fibromyalgia

1 reference

12 December 2020

Effect of gamma-hydroxybutyrate on pain, fatigue, and alpha sleep anomaly in patients with fibromyalgia.

1 reference

12 December 2020

Pain analysis in patients with fibromyalgia. Effects of intravenous morphine, lidocaine, and ketamine.

1 reference

12 December 2020

A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia

1 reference

12 December 2020

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

12 December 2020

Antidepressant treatment of fibromyalgia. A meta-analysis and review

1 reference

12 December 2020

Biology and therapy of fibromyalgia. New therapies in fibromyalgia

1 reference

12 December 2020

Modulatory influence on somatosensory perception from vibration and heterotopic noxious conditioning stimulation (HNCS) in fibromyalgia patients and healthy subjects.

1 reference

12 December 2020

A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia

1 reference

12 December 2020

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

12 December 2020

Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome

1 reference

12 December 2020

Slow-frequency rTMS reduces fibromyalgia pain

1 reference

12 December 2020

A double-blind placebo controlled trial of fluoxetine in fibromyalgia.

1 reference

12 December 2020

Fibromyalgia in women. Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels.

1 reference

12 December 2020

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

The neuroscience and endocrinology of fibromyalgia

1 reference

12 December 2020

Management of fibromyalgia syndrome

1 reference

12 December 2020

Efficacy of tramadol in treatment of pain in fibromyalgia.

1 reference

12 December 2020

Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale

1 reference

12 December 2020

Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial

1 reference

12 December 2020

Efficacy of milnacipran in patients with fibromyalgia.

1 reference

12 December 2020

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

1 reference

12 December 2020

A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with fibromyalgia.

1 reference

12 December 2020

Fibromyalgia patients show an abnormal dopamine response to pain

1 reference

12 December 2020

10.1007/S11916-008-0068-4

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18973731